Skip to Content

Advancing Clinical Research

Last Updated: November 6, 2025

By: Ginger Blackmon | Donald Harvey

How do phase I trials become real-world breakthroughs?

In this episode, R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO, Vice President of Clinical Research and Executive Director of the Emory Clinical Research Office, joins hosts Ginger Blackmon, PharmD, and Maddy Floysand, PharmD, for an inside look at how early-phase clinical trials lay the groundwork for new cancer therapies.

Dr. Harvey, who also serves as Professor of Hematology/Medical Oncology and Pharmacology and Associate Dean for Clinical Research at Emory University, discusses how phase I studies are evolving to balance discovery, safety, and patient care, and how access is expanding beyond academic centers.

He talks about:

  • How early-phase trials shape the future of oncology treatments
  • Collaboration between academic and community sites to improve access and equity
  • The vital role of pharmacists in study design, safety, and education
  • How AI and data are changing trial design and patient matching
  • Advice for clinicians and students interested in research careers

Dr. Harvey also reflects on the teamwork that drives meaningful progress — and what continues to inspire him after decades of leading research that connects science to patient impact.

Download Episode